Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 23682178)

1.

Comparative study of extended versus short term thromboprophylaxis in patients undergoing elective total hip and knee arthroplasty in Indian population.

Nair V, Kumar R, Singh BK, Sharma A, Joshi GR, Pathak K.

Indian J Orthop. 2013 Mar;47(2):161-7. doi: 10.4103/0019-5413.108953.

2.

Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.

Schiff RL, Kahn SR, Shrier I, Strulovitch C, Hammouda W, Cohen E, Zukor D.

Chest. 2005 Nov;128(5):3364-71.

PMID:
16304285
3.

Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.

Anderson FA Jr, Hirsh J, White K, Fitzgerald RH Jr; Hip and Knee Registry Investigators.

Chest. 2003 Dec;124(6 Suppl):349S-356S.

PMID:
14668417
4.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
5.
6.

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.

Comp PC, Spiro TE, Friedman RJ, Whitsett TL, Johnson GJ, Gardiner GA Jr, Landon GC, Jové M; Enoxaparin Clinical Trial Group.

J Bone Joint Surg Am. 2001 Mar;83-A(3):336-45.

PMID:
11263636
7.
8.

Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials.

Xing KH, Morrison G, Lim W, Douketis J, Odueyungbo A, Crowther M.

Thromb Res. 2008;123(1):24-34. doi: 10.1016/j.thromres.2008.05.005. Epub 2008 Jul 11. Review.

PMID:
18620740
9.
10.

Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.

Dager WE.

Ann Pharmacother. 2012 Jan;46(1):79-88. doi: 10.1345/aph.1P626. Epub 2011 Dec 27. Review.

PMID:
22202495
12.

Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.

Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Turpie AG, Wildgoose P, Yusen RD.

J Thromb Thrombolysis. 2006 Aug;22(1):31-8.

PMID:
16786230
13.

Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery.

Quinlan DJ, Eikelboom JW, Dahl OE, Eriksson BI, Sidhu PS, Hirsh J.

J Thromb Haemost. 2007 Jul;5(7):1438-43. Epub 2007 Apr 7.

PMID:
17425687
14.

Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.

Fitzgerald RH Jr, Spiro TE, Trowbridge AA, Gardiner GA Jr, Whitsett TL, O'Connell MB, Ohar JA, Young TR; Enoxaparin Clinical Trial Group.

J Bone Joint Surg Am. 2001 Jun;83-A(6):900-6.

PMID:
11407799
15.
16.
17.

The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial.

Raftopoulos I, Martindale C, Cronin A, Steinberg J.

Surg Endosc. 2008 Nov;22(11):2384-91. doi: 10.1007/s00464-008-0031-9. Epub 2008 Jul 12.

PMID:
18622558
18.

Deep vein thrombosis after total hip and knee arthroplasty in Indian patients.

Jain V, Dhaon BK, Jaiswal A, Nigam V, Singla J.

Postgrad Med J. 2004 Dec;80(950):729-31.

19.
20.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group.

N Engl J Med. 2008 Jun 26;358(26):2765-75. doi: 10.1056/NEJMoa0800374.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk